Storer v. Clark

E-Law Admin/ Juni 21, 2017/ Arzneimittelrecht Schweiz/ 0Kommentare

Storer v. Clark, 15-1802

In a patent interference case relating to a treatment for hepatitis C, the district court’s judgment is affirmed where the appellant’s provisional specification lacked enough information to synthesize the target compound and therefore did not support a claim of priority and interference.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/06/21

Judges

Court

  • United States Federal Circuit

Counsel


e-Law Trainer

Share this Post

Hinterlasse einen Kommentar